A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
Status: ENROLLING_BY_INVITATION
Study type: INTERVENTIONAL
Conditions: Prostate Cancer|Breast Cancer|Neuroendocrine Tumors
Interventions: DIAGNOSTIC_TEST: Total-body PET imaging
Sponsor: University of California, Davis
Collaborators: Lantheus Medical Imaging